Home
Contact Us
Site Map
 
 

Press Releases

May 2013
5/16/2013 Eisai Highlights New Research on Melanoma, Breast and Endometrial Cancer at ASCO Annual Meeting
5/9/2013 Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
5/8/2013 Publication in Federal Register Tomorrow Moves BELVIQ® (lorcaserin HCl) Closer To Launch
 
April 2013
4/18/2013 Eisai to Sponsor 7th Annual National Walk For Epilepsy to Help Raise Epilepsy Awareness
-- 4 Paws for Ability Service Dogs to Greet Visitors at Eisai Event Booth --
4/11/2013 Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
Newly Created Position to Strengthen Clinical Research
 
March 2013
3/26/2013 FDA Approves ACIPHEX® Sprinkle™ (Rabeprazole Sodium) For Use in Children Ages 1 to 11
 
February 2013
2/21/2013 Valeant Pharmaceuticals Acquires U.S. Rights to Targretin® from Eisai Inc.
2/14/2013 FDA Grants Orphan Drug Status to Eisai's Lenvatinib
2/4/2013 Morphotek Inc. Pilot Plant Receives 2013 Facility Of The Year Award
 
January 2013
1/10/2013 Morphotek Announces Top-Line Results Of A Phase III Study Of Farletuzumab In Patients With Relapsed Platinum-Sensitive Epithelial Ovarian Cancer
 
View archived press releases

Printer Friendly Version

 
Go to Top